FDG positron emission tomography imaging of drug-induced pneumonitis

Annals of Nuclear Medicine

Volumn 22, Issue 4, 2008, Pages 335-338

  Morikawa, Miwa ^a   Demura, Yoshiki ^a   Mizuno, Shiro ^a   Ameshima, Shingo ^a   Ishizaki, Takeshi ^a   Okazawa, Hidehiko ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Drug induced pneumonitis; FDG PET; Interstitial pneumonitis

Indexed keywords

C REACTIVE PROTEIN; CARBOHYDRATE ANTIGEN; CORTICOSTEROID; FLUORODEOXYGLUCOSE F 18; PACLITAXEL; QUETIAPINE; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BREAST CANCER; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; FEMALE; HUMAN; INTERSTITIAL PNEUMONIA; LUNG INFILTRATE; MENTAL DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

AGED; ANXIETY DISORDERS; BRAIN NEOPLASMS; BREAST NEOPLASMS; DIBENZOTHIAZEPINES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; PNEUMONIA; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 44949153444     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-007-0109-9     Document Type: Article

References (17)

1. Higashi K, Matsunari I, Ueda Y, Ikeda R, Guo J, Oguchi M, et al. Value of whole-body FDG PET in management of lung cancer. Ann Nucl Med 2003;17:1-14.
2. Laking G, Price P. 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer. Thorax 2001;56Suppl 2:ii38-ii44.
3. El-Haddad G, Zhuang H, Gupta N, Alavi A. Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders. Semin Nucl Med 2004;34:313-329.
4. Demura Y, Tsuchida T, Ishizaki T, Mizuno S, Totani Y, Ameshima S, et al. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med 2003;44:540-548.
5. Tsujikawa T, Okazawa H, Tsuchida T, Demura Y, Imamura Y, Fujibayashi Y. A 18F-FDG-positive, 67Ga-negative, and transferrin receptor expression-negative patient with diffuse large B-cell lymphoma. Ann Nucl Med 2007;21:375-378.
6. Nishiyama Y, Yamamoto Y, Fukunaga K, Takinami H, Iwado Y, Satoh K, et al. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med 2006;47:1571-1576.
7. Hassaballa HA, Cohen ES, Khan AJ, Ali A, Bonomi P, Rubin DB. Positron emission tomography demonstrates radiation-induced changes to nonirradiated lungs in lung cancer patients treated with radiation and chemotherapy. Chest 2005;128:1448-1452.
8. Meissner HH, Soo Hoo GW, Khonsary SA, Mandelkern M, Brown CV, Santiago SM. Idiopathic pulmonary fibrosis: evaluation with positron emission tomography. Respiration 2006;73:197-202.
9. Kirsch J, Arrossi AV, Yoon JK, Wu G, Neumann DR. FDG positron emission tomography/computerized tomography features of bleomycin-induced pneumonitis. J Thorac Imaging 2006;21:228-230.
10. White DA. Drugs and the lungs: comprehensive respiratory medicine, Chap. 77. St. Louis: Mosby; 1999. p. 20.
11. Fraser RS, Muller NL, Colman N, Pare P. Drugs. In: Fraser RS, Par JAP, editors. Fraser and Pare's diagnosis of diseases of the chest. 4th ed. Philadelphia: WB Saunders; 1999. p. 2537-2583.
12. Miyata M, Sakuma F, Fukaya E, Kobayashi H, Rai T, Saito H, et al. Detection and monitoring of methotrexate-associated lung injury using serum markers KL-6 and SP-D in rheumatoid arthritis. Intern Med 2002;41:467-473.
13. Ishimori T, Saga T, Mamede M, Kobayashi H, Higashi T, Nakamoto Y, et al. Increased 18F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. J Nucl Med 2002;43:658-663.
14. Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 1995;36:1301-1306.
15. Hansson L, Ohlsson T, Valind S, Sandell A, Luts A, Jeppsson B, et al. Glucose utilisation in the lungs of septic rats. Eur J Nucl Med 1999;26:1340-1344.
16. Camus P, Kudoh S, Ebina M. Interstitial lung disease associated with drug therapy. Br J Cancer 2004;91Suppl 2:S18-S23.
17. Camus P. Interstitial lung disease in patients with non-small-cell lung cancer: causes, mechanisms and management. Br J Cancer 2004;91Suppl 2:S1-S2.